Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 1925-1932, December 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomisek, A. J.
Right arrow Articles by Reid, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomisek, A. J.
Right arrow Articles by Reid, M. R.

Chromatographic Studies of Purine Metabolism

VI. Inhibition of Inosine Phosphorylase by 6-Mercaptopurine1

Arthur J. Tomisek, Ann P. V. Hoskins and Mary R. Reid

Kettering-Meyer Laboratory Southern Research Institute,2 Birmingham, Alabama

The short-term effects of 6-mercaptopurine upon the intracellular metabolic pools of purines have been studied in Escherichia coli that were assimilating formate-14C, inosine-14C, adenosine-14C, guanosine-14C, or hypoxanthine-14C. Following the 15-min assimilation of the radioactive substrate, the soluble cell fraction components were separated by paper chromatography and assayed for radioactivity.

The strongest metabolic effect of 6-mercaptopurine observed was a large accumulation of inosine accompanied by a large decrease of hypoxanthine. This was taken as evidence for a previously unreported blockade of inosine phosphorylase. Although this effect was observed at 6-mercaptopurine levels as low as 5 µg/ml, at which level there was no inhibition of growth, it appeared to account for little if any of the growth inhibition at higher 6-mercaptopurine levels.

The known effect of 6-mercaptopurine in blocking the conversion of inosinic acid to adenylic acid was indeed in evidence, but the block was not sufficiently strong to act as a rate-limiting factor for growth.

1 Supported by Cancer Chemotherapy National Service Center, National Cancer Institute, under NIH Contract No. SA-43-ph-2433, and by grants from the Alfred P. Sloan Foundation and the Charles F. Kettering Foundation.

2 Affiliated with the Sloan-Kettering Institute for Cancer Research, New York, N. Y.

Received 3/ 8/65. Revised 7/ 9/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.